Concurrently, Moody’s assigned its “A3” rating on SGHS’ proposed $104 million series 2017 bonds.
The downgrade is a result of several factors, including SGHS’ heavy debt burden, high leverage position and weakened operating performance. Moody’s also acknowledged the health system’s dominant market position and maintenance of liquidity measures in recent years.
The outlook is negative, reflecting the health system’s decline in operating performance.
More articles on healthcare finance:
Why Harvard’s $37B endowment is at risk of mediocrity
12 hospitals seeking RCM talent
Irving family presents record $700M bequest to NewYork-Presbyterian, Columbia University
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.